CN Patent

CN110857304B — Trk抑制剂、其制备方法和用途

Assigned to Beijing Forelandpharma Co ltd · Expires 2021-05-18 · 5y expired

What this patent protects

本申请属于医药领域，具体涉及Trk抑制剂、其制备方法和用途。本发明主要涉及下式A1、式A2、式A3或式A4所示的化合物、及所述化合物中任一化合物的药学上可接受的盐、立体异构体、同位素标记物、溶剂化物、多晶形物或前药，及所述化合物的制备方法和应用

USPTO Abstract

本申请属于医药领域，具体涉及Trk抑制剂、其制备方法和用途。本发明主要涉及下式A1、式A2、式A3或式A4所示的化合物、及所述化合物中任一化合物的药学上可接受的盐、立体异构体、同位素标记物、溶剂化物、多晶形物或前药，及所述化合物的制备方法和应用

Drugs covered by this patent

Patent Metadata

Patent number
CN110857304B
Jurisdiction
CN
Classification
—
Expires
2021-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Forelandpharma Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.